11.00
전일 마감가:
$11.01
열려 있는:
$11
하루 거래량:
17,358
Relative Volume:
0.42
시가총액:
$44.48M
수익:
$147.75M
순이익/손실:
$-284.23M
주가수익비율:
-3.7543
EPS:
-2.93
순현금흐름:
$-317.54M
1주 성능:
+1.76%
1개월 성능:
-6.22%
6개월 성능:
+31.97%
1년 성능:
+35.22%
Fibrogen Inc Stock (FGEN) Company Profile
명칭
Fibrogen Inc
전화
415-978-1200
주소
350 BAY STREET, SAN FRANCISCO, CA
FGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
FGEN
Fibrogen Inc
|
11.00 | 44.52M | 147.75M | -284.23M | -317.54M | -2.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-06-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-26 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-06-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-06-26 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-06-02 | 업그레이드 | Stifel | Hold → Buy |
| 2023-01-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-01-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-09-22 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-08-20 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-07-16 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-07-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-04-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-04-07 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-03-31 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-02-01 | 개시 | H.C. Wainwright | Buy |
| 2020-10-26 | 개시 | Raymond James | Underperform |
| 2020-07-10 | 재개 | Stifel | Buy |
| 2020-05-01 | 개시 | Cowen | Market Perform |
| 2020-04-27 | 개시 | BofA/Merrill | Neutral |
| 2019-05-29 | 재개 | Goldman | Neutral |
| 2019-05-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-04-12 | 개시 | Piper Jaffray | Neutral |
| 2019-02-11 | 재개 | Stifel | Buy |
| 2018-12-19 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-08-08 | 재확인 | Leerink Partners | Outperform |
| 2017-08-08 | 재확인 | Stifel | Buy |
| 2017-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2017-07-11 | 개시 | Jefferies | Buy |
| 2016-02-11 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2016-01-21 | 개시 | Credit Suisse | Neutral |
| 2015-12-04 | 개시 | Citigroup | Buy |
| 2015-09-23 | 개시 | Lake Street | Hold |
| 2015-07-29 | 개시 | Citigroup | Buy |
| 2015-07-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2014-12-09 | 개시 | Stifel | Buy |
모두보기
Fibrogen Inc 주식(FGEN)의 최신 뉴스
Will earnings trigger a reversal in FibroGen Inc.Market Activity Report & Low Risk Entry Point Guides - newser.com
Chart based exit strategy for FibroGen Inc.Weekly Loss Report & Safe Capital Growth Tips - newser.com
Backtesting results for FibroGen Inc. trading strategiesJuly 2025 Institutional & Momentum Based Trading Ideas - newser.com
How to read the order book for FibroGen Inc.Portfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Is FibroGen Inc. (1FG0) stock expanding market penetrationMarket Weekly Review & Low Volatility Stock Suggestions - newser.com
FibroGen to Report Third Quarter 2025 Financial Results - The Manila Times
FibroGen (NASDAQ: FGEN) sets Q3 results; 5:00 PM ET conference call Monday - Stock Titan
What does recent volatility data suggest for FibroGen Inc.2025 Price Targets & Community Consensus Picks - newser.com
Should you hold or exit FibroGen Inc. nowQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Is FibroGen Inc. stock ready for a breakoutWeekly Market Report & Free High Return Stock Watch Alerts - newser.com
Building trade automation scripts for FibroGen Inc.Weekly Trend Summary & Safe Capital Investment Plans - newser.com
Is FibroGen Inc. reversing from oversold territoryTrade Volume Report & High Conviction Buy Zone Picks - newser.com
What to expect from FibroGen Inc. in the next 30 days2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com
Forecasting FibroGen Inc. price range with options dataJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
What hedge fund activity signals for FibroGen Inc. stock2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Technical signs of recovery in FibroGen Inc.July 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
Can FibroGen Inc. stock outperform in 2025 bull marketEarnings Trend Report & Reliable Entry Point Trade Alerts - newser.com
How to integrate FibroGen Inc. into portfolio analysis toolsGlobal Markets & Risk Adjusted Swing Trade Ideas - newser.com
Can FibroGen Inc. stock sustain institutional interestJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Why FibroGen Inc. stock attracts global investorsTrend Reversal & Precise Buy Zone Identification - newser.com
Can FibroGen Inc. (1FG0) stock reach $200 price target2025 Price Action Summary & Community Driven Trade Alerts - newser.com
What analysts say about FibroGen Inc 1FG0 stockShort-Term Trading Alerts & Minimal Capital Growth Plans - earlytimes.in
Is FibroGen Inc. stock attractive for hedge fundsEarnings Risk Report & AI Driven Stock Reports - newser.com
Fibrogen Inc (FGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fibrogen Inc 주식 (FGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Wettig Thane | CEO |
Mar 24 '25 |
Buy |
0.35 |
145,000 |
50,663 |
543,329 |
| Schoeneck James A | Director |
Mar 20 '25 |
Buy |
0.35 |
250,000 |
88,000 |
323,722 |
| Schoeneck James A | Director |
Mar 21 '25 |
Buy |
0.34 |
50,000 |
17,040 |
373,722 |
자본화:
|
볼륨(24시간):